Epidemiology;Treatment of Inhibitors in Hemophiliacs; Hemophilic Arthropathy and Synovitis; Relevant Hemophilia Treatment 2006; Pediatric Hemostasiology; Free Lectures
E-Book, Englisch, 286 Seiten, eBook
ISBN: 978-3-540-73535-9
Verlag: Springer
Format: PDF
Kopierschutz: Wasserzeichen (»Systemvoraussetzungen)
Zielgruppe
Research
Autoren/Hrsg.
Weitere Infos & Material
Johann Lukas Schoenlein Prize 2006.- Johann Lukas Schoenlein Prize 2006.- Epidemiology.- HIV Infection and Causes of Death in Patients with Hemophilia in Germany (Year 2005/2006 Survey).- Hemophilia Registry of the Medical Committee of the Swiss Hemophilia Association — Update and Annual Survey 2006.- Treatment of Inhibitors in Hemophiliacs.- Detection of Factor VIII-Specific Memory B Cells in Patients with Hemophilia A and Factor VIII Inhibitors.- Novel Strategies for FVIII: Half-life Prolongation.- Hemophilic Arthropathy and Synovitis.- Predictive Parameters of Fitness in Hemophiliac Children.- Hemophilia and Exercise Project (HEP) Conception and Contents of a “Programmed Sports Therapy” for Hemophilic Patients.- Results of German Hemophiliacs Self-Assessment of Health and Social Status: With Emphasis on Orthopedic Function.- Relevant Hemophilia Treatment 2006.- Developing a German Hemophilia Register.- Pediatric Hemostasiology.- Thrombin Generation in Children with Hemophilia and VWD — Comparing a Fluorimetric Method and ROTEM.- Thrombin Generation in Severely Obese Children.- Protein C Promoter Genotypes Associate with Susceptibility, Development of Sepsis, and Lower Blood Pressure in Young Children with Systemic Meningococcemia.- Life of Teenage Hemophiliacs.- Free Lectures.- Monocytes Enhance rVIIa Induced Thrombin Generation in Absence of Platelets and Microparticles.- Mutation Detection Rate in Female Patients with Reduced Factor VIII Activity and Negative Family History for Hemophilia A.- Investigation of Underlying Reasons of Factor VIII Deficiency in Hemophilia A Patients with Undetectable Mutations in the F8 Gene.- Monitoring of Antiplatelet Therapy Using Whole Blood Aggregometry: Experiences and Approaches to Dose Adaptation.- Poster.- No Complications in Switching from Recombinate to Advate — a Prospective Surveillance in 22 Children.- Epidemiology and Treatment of Hemophilia A, B and von Willebrand Disease of Type 3 in the Eastern Part of German.- Database Management System for a Hemophilia Comprehensive Care Center.- Hepatocellular Carcinoma in Patients with Hemophilia and Chronic Hepatitis C Infection.- Elucidation of Gross Genomic Rearrangements Involving Large Deletions in the Clotting Factor VIII Gene.- The Centro American Hemophilia Registry, of the CARS Hemophilia Group — Update September 2006.- Two Examples of the Influence of Psychological Stress on the von Willebrand Factor Activity.- Efficacy of Chronic Hepatitis C Treatment in Hemophilic Patients During the Last 10 Years: a Single Center Experience.- Dynamic of Thrombin Generation in Patients with Severe Hemophilia A.- Hemophilia and Exercise Project (HEP): Effects of a Two-Year Sports Therapy on Physical Activity Behavior and Bleeding Frequency by Persons with Hemophilia.- Hemophilia Summer Camp in Germany, 1996–2005.- Impact of Hemophilia on the Psychological Health of Hemophilia Patients in Romania.- Starter-Kit for Patients Suffering from Hemophilia — A Project Initiated by the German Hemophilia Assistant Committee.- Documentation in Hemophilia Treatment.- Short-time Prophylaxis with FEIBA in Three Patients with Hemophilia A and High Titer Inhibitors.- Successful Treatment of a Patient with High Titer Acquired Factor VIII Inhibitor (114 BU) with Rituximab.- Preoperative Arterial Embolization of a Hemophilic Pseudo Tumor before Osteosynthesis in a Patient with Hemophilia A and Pathological Femoral Fracture.- Successful Liver Transplantation in Two Patients with Severe Hemophilia A.- Out from the Cold: Severe Erythema and Clumped Red Cells.- Acquired Glanzmann Thrombasthenia in a Patient with Myelodysplastic Syndrome.- Case Report of an Acquired Inhibitor Against Factor XIII.- Elbow Endoprosthesis in Hemophilic Arthropathy.- Pseudohomozygous APC Resistance Report on Two Patients and a Novel Mutation in the Factor V Gene.- Pseudo-Homozygous APC Resistance Due to Coinheritance of Heterozygous Factor V — R506Q and Type I Deficiency Associated with Thrombosis.- Three Cases of In-stent Thrombosis in Patients with Clopidogrel Non-response.- Thrombin Generation in Pregnancy.- Thrombin Generation — Comparison of ROTEM and Technothrombin TGA.- Multiple Electrode Aggregometry in Patients on Chronic Aspirin and/or Clopidogrel Treatment.- Endogenous Thrombin Potential in Women with Recurrent Miscarriage and/or Repeated In-Vitro-Fertilization Failure.- One Year TTP Diagnosis in the Central Laboratory of the University of Mainz.- Venous Thromboembolism — A Metabolic Disease?.- Structural Investigation of Two Novel Mutations in Coagulation Factor V by Molecular Modeling.- High Levels of Human Factor IX Transgene Expression in Mice Increase Blood Procoagulant Activity.- Factor VII Deficiency: Clinical Manifestation and Molecular Genetics of 718 Subjects with FVII Gene Mutations.- Therapeutical Options for Congenital FVII Deficiency — The HK 7 Project of the International Greifswald Registry of the Congenital FVII Deficiency (GR-HK-7).- Characterization of a Mutation in Exon 1 of the FVII Gene — a Case of RNA Editing?.- Analysis of the Biological Importance of the VKORC1 Gene via Knock-Out Mice.- In Vivo-Assay for Warfarin-Resistance by Coexpression of VKORC1 and Vitamin K-Dependent Coagulation Factors.- Functional Promoter Polymorphism in the VKORC1 Gene is no Major Genetic Determinant for Vitamin K Dependent Coagulation Factor Activity.- Influence of VKORC1 Haplotypes on Cardiovascular Disease.- Creation and Characterization of a Knock-Out Mouse for the VKORC1L1-Gene.- Novel Variants in VKORC1 — the Target Protein of Cumarin-Type Anticoagulants — in Rodents from Warfarin-Resistance Areas in Europe, Asia and America.- Recombinant Expression and 3D-Modelling of C1-Inhibitor Mutants.- Five Novel Mutations in F13B Gene Resulting in Mild FXIII Deficiency.- Idiopathic Thrombocytopenic Purpura in Children: Predictive Factors for the Outcome.- Preoperative DDAVP-Testing in Patients with von Willebrand Disease.
